Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation.

Ridker PM, Glynn RJ, Miletich JP, Goldhaber SZ, Stampfer MJ, Hennekens CH.

Ann Intern Med. 1997 Apr 1;126(7):528-31.

PMID:
9092318
2.

Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.

Price DT, Ridker PM.

Ann Intern Med. 1997 Nov 15;127(10):895-903. Review.

PMID:
9382368
4.

Effects of oral contraceptives on hemostasis and thrombosis.

Rosing J, Tans G.

Am J Obstet Gynecol. 1999 Jun;180(6 Pt 2):S375-82. Review.

PMID:
10368524
5.

Factor V Leiden: should we screen oral contraceptive users and pregnant women?

Vandenbroucke JP, van der Meer FJ, Helmerhorst FM, Rosendaal FR.

BMJ. 1996 Nov 2;313(7065):1127-30. Review.

6.

Epidemiology of factor V Leiden: clinical implications.

De Stefano V, Chiusolo P, Paciaroni K, Leone G.

Semin Thromb Hemost. 1998;24(4):367-79. Review.

PMID:
9763354
7.

Factor V Leiden: a case study and review.

Slusher KB.

Dimens Crit Care Nurs. 2010 Jan-Feb;29(1):6-10. doi: 10.1097/DCC.0b013e3181be4985. Review.

PMID:
20010186
8.

Factor V:Q506 mutation-resistance to activated protein C (APC): clinical implications with respect to family screening.

Middeldorp S, van der Meer J.

Semin Thromb Hemost. 1998;24(4):363-6. Review.

PMID:
9763353
9.

Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis.

Bertina RM, Reitsma PH, Rosendaal FR, Vandenbroucke JP.

Thromb Haemost. 1995 Jul;74(1):449-53. Review.

PMID:
8578504
10.

The effect of factor V Leiden carriage on maternal and fetal health.

Bloomenthal D, von Dadelszen P, Liston R, Magee L, Tsang P.

CMAJ. 2002 Jul 9;167(1):48-54. Review.

12.

Venous thrombosis revisited.

Thomas DP.

Blood Coagul Fibrinolysis. 1996 Sep;7(6):583-5. Review.

PMID:
8899145
13.

APC resistance in childhood thromboembolism: diagnosis and clinical aspects.

Nowak-Göttl U, Schneppenheim R, Vielhaber H.

Semin Thromb Hemost. 1997;23(3):253-8. Review.

PMID:
9255906
14.

[Oral contraception increases the chance of venous thrombosis in factor V Leiden mutation].

Vandenbroucke JP, Briët E, Helmerhorst F, van der Meer FJ.

Ned Tijdschr Geneeskd. 1995 May 27;139(21):1067-71. Review. Dutch. No abstract available.

PMID:
7783798
15.

Venous thrombosis in the elderly: incidence, risk factors and risk groups.

Engbers MJ, van Hylckama Vlieg A, Rosendaal FR.

J Thromb Haemost. 2010 Oct;8(10):2105-12. doi: 10.1111/j.1538-7836.2010.03986.x. Review.

16.

Resistance to activated protein C: role in venous and arterial thrombosis.

Emmerich J, Alhenc-Gelas M, Aiach M, Fiessinger JN.

Biomed Pharmacother. 1996;50(6-7):254-60. Review.

PMID:
8952864
17.

[Recently discovered frequent cause of venous thrombosis: factor V Leiden, a mutated factor V, resistant against protein C inactivation].

Rosendaal FR.

Ned Tijdschr Geneeskd. 1994 Sep 24;138(39):1944-8. Review. Dutch. No abstract available.

PMID:
7935943
18.

Factor V Leiden: how great is the risk of venous thromboembolism?

Shaheen K, Alraies MC, Alraiyes AH, Christie R.

Cleve Clin J Med. 2012 Apr;79(4):265-72. doi: 10.3949/ccjm.79a.11072. Review.

PMID:
22473726
19.

Protein Z.

Kemkes-Matthes B, Matthes KJ.

Semin Thromb Hemost. 2001 Oct;27(5):551-6. Review.

PMID:
11668427
20.

Factor V Leiden and inflammatory bowel disease: a systematic review and meta-analysis.

Liang J, Wu S, Feng B, Lei S, Luo G, Wang J, Li K, Li X, Xie H, Zhang D, Wang X, Wu K, Miao D, Fan D.

J Gastroenterol. 2011 Oct;46(10):1158-66. doi: 10.1007/s00535-011-0441-7. Epub 2011 Jul 30. Review.

PMID:
21805067

Supplemental Content

Support Center